Biotechnology · Healthcare
Head of Investor Relations
Head of Investor Relations
Nautilus Biotechnology, Inc. (NAUT)Equibles does not estimate personal net worth.
Get an email with a short summary when Nautilus Biotechnology, Inc. publishes a filing, an earnings call transcript or a press release.
Get NAUT alertsMarissa is recorded as Head of Investor Relations at Nautilus Biotechnology, Inc. (NAUT). Marissa has spoken on 1 earnings call across 1 company, most recently for Nautilus Biotechnology, Inc. on October 27, 2026. Nautilus Biotechnology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Nautilus Biotechnology, Inc. includes Sujal Patel (CEO and Board Member), Anna Mowry (CFO), Matt Murphy (General Counsel) and 7 others.
“Earlier today, Nautilus released financial results for the quarter ended September 30, 2026.”
Biotechnology · Healthcare
Head of Investor Relations